Introduction
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly named Churg-Strauss syndrome, is a rare systemic small-and medium-sized-vessel vasculitis, characterized by the presence of severe asthma as well as blood and tissue eosinophilia. It is one of the less common vasculitides with a prevalence that ranges from 10.7 to 13 cases/million inhabitants [1] . Characteristic histopathologic features include necrotizing vasculitis in veins or arteries with infiltration mainly by eosinophils in vessels and surrounding tissues. Gastro-intestinal (GI) involvement has been reported to occur in approximately 50% of EGPA patients; however, there are few reports of histologic evidence of GI involvement. Symptoms include abdominal pain, vomiting and diarrhea. Few reports have described the actual pathology as it is difficult to document, but the small bowel is most commonly affected, followed by the stomach and colon. We report the case of a patient on treatment for EGPA who presented with recurrent small bowel obstruction and choledocholithiasis.
Case Presentation
A 64-year-old gentleman with a past medical history significant for EGPA presented to our gastroenterology clinic after recurrent episodes of partial small bowel obstruction within a period of 6 weeks. The diagnosis of EGPA had been done 12 years before when he presented with asthma exacerbation associated with extremity petechiae, purpura and digital infarcts as well as amaurosis and temporal artery swelling. Two years previous to his presentation, the patient had several times undergone endoscopic retrograde cholangiopancreatography (ERCP) for recurrent choledocholithiasis with associated cholangitis. Biopsies had shown acute and chronic inflammation with reactive epithelial changes presumably secondary to stones. The vasculitis had been stable on methotrexate and prednisone with serial stable inflammatory markers and absolute eosinophils prompting a reduction in immune suppression 3 months prior to presentation.
On presentation, the patient was having recurrent, episodic abdominal pain associated with intermittent abdominal distention and new lower extremity purpuric lesions. Physical examination was otherwise within normal limits. Elevated inflammatory markers and eosinophilia of 0.69 × 10 9 /l (13.5%) were detected. Magnetic resonance enterography was performed to further evaluate the cause of the recurrent small bowel obstruction. It showed bowel wall thickening in the distal small bowel, with mechanical small bowel obstruction proximal to the ileocecal valve ( fig. 1 ). Given his history of recurrent cholangitis, ERCP with cholangiogram was performed which showed moderate dilation of the biliary tree. Cholangioscopy showed a nodular common bile duct, with one stone in the left intrahepatic duct which was successfully removed. Common bile duct biopsies showed eosinophils and mononuclear cells with some associated fibrosis ( fig. 2 ).
Extended enteroscopy was performed to evaluate the upper GI tract. Erythematous mucosa in the gastric fundus and body, nodular mucosa in the gastric antrum and multiple small duodenal polyps were identified. The esophagus, the remaining duodenum and the jejunum were normal. Biopsies of the normal and diseased mucosa showed a diffuse dense inflammatory infiltrate in the lamina propria including mononuclear cells and eosinophils (>50 eosinophils per high-power field). On immunohistochemistry, T and B cells showed normal immunophenotype, and in situ hybridization for Epstein-Barr virus was negative, findings that ruled out lymphoma.
Retrograde balloon-assisted enteroscopy showed congested and thickened folds of the mucosa in the distal ileum biopsies with normal colon. Pathology showed blunted villi, with an inflammatory expansion of the lamina propria including the presence of increased eosinophils ( fig. 3 ). Table 1 summarizes the macroscopic and pathologic findings.
Magnetic resonance angiography was performed and no signs of significant mesenteric artery stenosis or other vascular abnormality were identified. All findings were consistent with Churg-Strauss syndrome involving the GI tract even though no vasculitis was shown on pathology. Although surgery of the ileal stricture was considered, medical management with increased dose of methotrexate and prednisone was elected. Unfortunately, after 2 months of being totally asymptomatic on higher-dose immune suppression the patient experienced a syncopal event and died. Clinically, this was attributed to known pre-existing heart disease likely due to EGPA involvement.
Discussion
EGPA, formerly known as Churg-Strauss syndrome, was first described in 1951 by Jacob Churg and Lotte Strauss as a form of vasculitis that included necrotizing vasculitis, eosinophilic infiltrates and granulomata [2] . Although it is classified as a vasculitis, the affected tissue usually does not show necrotizing vasculitis or granulomata, but rather an apparently nondestructive infiltration of the vessel walls by eosinophils; in fact, only 40-60% of patients with EGPA have anti-neutrophil cytoplasmic antibodies (ANCAs) [3, 4] . For this reason the diagnostic criteria remain clinical (table 2). Our patient had negative ANCAs but a clinical diagnosis of EGPA. EGPA is one of the less common vasculitides with a prevalence ranging from 10.7 to 13 cases/million inhabitant, and three disease phases have been proposed: (1) a prodromal phase that is characterized by atopic disease, (2) an eosinophilic phase, with blood eosinophilia, and (3) a vasculitic phase, with eosinophilia involving medium-and small-sized vessels [5, 6] . GI involvement may precede or present concurrent with the vasculitic phase.
The respiratory tract is almost constantly involved, but any organ system can be affected. Of all the systemic manifestations, GI involvement has a negative prognostic factor, especially if mesenteric infarction and bowel perforation are present [7] . GI involvement has been reported to occur in approximately 50% of patients with a diagnosis of EGPA, symptoms including abdominal pain, vomiting and diarrhea [8] . For few cases the actual pathology has been described as it is difficult to document. Pathologic findings include multiple ulcerations, perforation, obstruction and ileus with documented eosinophilia and granulomata. Ischemic changes in the GI tract are rarely documented as the GI tract has a robust collateral blood supply reducing the incidence of ischemia. Histologic vasculitis is rarely seen on biopsy sections as endoscopic biopsies are too superficial to adequately sample submucosal vessels [8] .
Although eosinophilic infiltration of the GI tract can represent a spectrum of pathologic conditions, including EGPA and hypereosinophilic syndrome, our patient fulfilled the clinical criteria for EGPA, and although no vasculitis was documented in this patient's biopsies, the eosinophilia was sufficient for the diagnosis. The lack of vasculitis could be attributed to the aforementioned sampling issues related to endoscopic biopsy. Alternatively, perhaps this patient had not yet progressed from the eosinophilic phase to a vasculitic phase. Previous reports have shown that the small bowel is the most commonly involved region of the GI tract, followed by the stomach and the colon [9] . Our patient's GI compromise was remarkable because of its diffuse distribution, including the biliary tree. Biopsies of the common bile duct showed inflammation which could be attributed to EGPA, as published cases have documented acalculous cholecystitis associated with this type of vasculitis [10, 11] . However, the exact etiology of the common bile duct changes in our patient remained unclear, as he also had documented recurrent episodes of choledocholithiasis, which may have similar histologic findings. Treatment of the vasculitis includes corticosteroids, but usually during a flair, steroids with cytotoxic medications are required to induce remission. Depending on the degree of GI involvement, patients may require surgical resection; this is an indicator of poor prognosis [12] .
In summary, the diagnosis of EGPA in the GI tract requires high clinical suspicion as histologic documentation of vasculitis may be unavailable and eosinophilia may be the only finding. Improved awareness of GI EGPA may allow for timely management of this disorder. Four out of six criteria should be present. 
